My MS Toolkit: An Internet-Based Depression Self-Management Program for Adults Living With Multiple Sclerosis

Not yet recruitingNot a drug-phase studyMS (type not specified)NCT07636434

What it found

Still running

No result yet.

What was tested

Treatment tested

  • My MS Toolkit

What it measured

Main measures

  • Depressive Symptom Severity

    Baseline (prior to treatment), 12-week and 4-month

    Mood and sleepQuality of life (reported by participants)

Other measures (12)

  • Sleep Disturbance

    Baseline (prior to treatment), 12-week, and 4-month

    Mood and sleepQuality of life (reported by participants)
  • Fatigue Severity

    Baseline (prior to treatment), 12-week, and 4-month

    FatigueQuality of life (reported by participants)
  • Fatigue Impact

    Baseline (prior to treatment), 12-week, and 4-month

    Thinking and memoryFatigue
  • Pain Intensity

    Baseline (prior to treatment), 12-week, and 4-month

    PainQuality of life (reported by participants)
  • Anxiety

    Baseline (prior to treatment), 12-week, and 4-month

    Mood and sleepQuality of life (reported by participants)
  • Pain Interference

    Baseline (prior to treatment), 12-week, and 4-month

    PainQuality of life (reported by participants)
  • Social Participation

    Baseline (prior to treatment), 12-week, and 4-month

    PainQuality of life (reported by participants)
  • Treatment Engagement

    12-week and 4-month

  • Treatment Satisfaction

    12-week and 4-month

    Quality of life (reported by participants)
  • Treatment Recommendation

    12-week and 4-month

    Mood and sleep

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* Self-reported diagnosis of MS (with screening questions such as current disease modifying therapy) * At least 18 years of age * Can read, write, and speak in English * Score of >4 on the Patient Health Questionnaire, indicating at least mild depressive symptoms * Have access to an internet-connected device for accessing the intervention

Exclusion criteria

* Previous diagnosis of bipolar disorder or schizophrenia * Started medication for depression or anxiety in the past 2 months * Currently undergoing psychotherapy for depression * Are of moderate or high risk for suicide on the Columbia Suicide Severity Rating Scale (C-SSRS) * Participating in another clinical trial

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

We are conducting this study to test if the new Toolkit depression module is accessible and helpful for people with multiple sclerosis (MS) in decreasing depression severity.

Loading reviews and guidelines…

History

    1. Started

      Sept 2026

    2. Main results due

      Sept 2027

    3. Finished

      Nov 2027

    Assembled by software from public sources.